Product Information
FT ALLERGY (FEXO) 180 MG TAB is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.2302 per EA under NDC 70677125602. Its NADAC has been published 62 times since Jul 30, 2025.
FDA first approved this application on Aug 19, 2016.
Strength
180 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677125602
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FEXOFENADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204097FDA Approved
8/19/2016
On Market Since
5/1/2025
Pharmacological Classes
Price Statistics
The NADAC for FT ALLERGY (FEXO) 180 MG TAB has been published 62 times since Jul 30, 2025, and over the history we have for it it has declined 10.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2302 per EA |
|---|---|
| All-time high | $0.2728 (Dec 10, 2025) |
| All-time low | $0.2302 (Sep 23, 2026) |
| 52-week high | $0.2728 |
| 52-week low | $0.2302 |
| Median price | $0.2547 |
| Average price | $0.2544 |
| Largest weekly change | -4.9% (Feb 18, 2026) |
| Weeks tracked | 62 |
| Tracking since | Jul 30, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fexofenadine HCL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT ALLERGY (FEXO) 180 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for FT ALLERGY (FEXO) 180 MG TAB, manufactured by Strategic Sourcing Services LLC, is $0.2302 per EA (NDC 70677125602), effective Sep 30, 2026.
How has the price of FT ALLERGY (FEXO) 180 MG TAB changed over time?
Over the history we have for it, the NADAC for FT ALLERGY (FEXO) 180 MG TAB has declined 10.2%. It has been tracked across 62 weekly CMS publications since Jul 30, 2025.
What are the highest and lowest recorded NADAC prices for FT ALLERGY (FEXO) 180 MG TAB?
Since Jul 30, 2025, the NADAC for FT ALLERGY (FEXO) 180 MG TAB has ranged from a low of $0.2302 (Sep 23, 2026) to a high of $0.2728 (Dec 10, 2025), with a median of $0.2547 per EA.
Are there cheaper alternatives to FT ALLERGY (FEXO) 180 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FT ALLERGY (FEXO) 180 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures FT ALLERGY (FEXO) 180 MG TAB?
FT ALLERGY (FEXO) 180 MG TAB (NDC 70677125602) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.